Clinical Trial Update: Effect of Intravenous Nalbuphine and Magnesium Sulfate on Emergence Agitation in Pediatric [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating intravenous nalbuphine and magnesium sulfate for emergence agitation in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence Delirium

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)
• Nalbuphine (nalbuphine)

Snippet

Sponsor: Assiut University | Conditions: Emergence Delirium | Phase 3 | Status: UNKNOWN